Visceral steatosis, congenital
MONDO:0009220Also known as: visceral steatosis, congenital, White liver disease, fatal neonatal hepatic steatosis, fatty liver disease, congenital, fatty metamorphosis of viscera, steatosis of liver, visceral steatosis
8 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Weight-Loss drugs may offer early liver protection, study suggests
Knowledge-focused CompletedThis study looks at whether two popular weight-loss medications, semaglutide and tirzepatide, can improve early signs of liver damage in people with overweight or obesity. Researchers measured changes in liver health markers after at least 12 weeks of treatment in 154 adults. The…
Sponsor: Goztepe Prof Dr Suleyman Yalcın City Hospital • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Blood tests could spot hidden liver risk in diabetics
Knowledge-focused CompletedThis completed study observed 40 people with type 2 diabetes to find blood markers that could identify those at risk for a serious liver condition called NASH. Researchers measured liver stiffness and calculated scores like FIB-4 and ELF to see which patients might have liver sca…
Sponsor: Faculty Hospital Kralovske Vinohrady • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
10,000 seniors studied to predict fatty liver dangers
Knowledge-focused CompletedThis study looked at 10,000 older adults (age 60+) with fatty liver disease to find out what increases their risk for serious liver problems like scarring, cirrhosis, or liver cancer. Researchers used medical records and yearly check-ups to build a computer model that predicts th…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC